- Home
- GPRO vs EPRX Comparison
GPRO vs EPRX Comparison
Compare GPRO & EPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GPRO
- EPRX
- Stock Information
- Founded
- GPRO 2004
- EPRX 2011
- Country
- GPRO United States
- EPRX Canada
- Employees
- GPRO N/A
- EPRX N/A
- Industry
- GPRO Industrial Machinery/Components
- EPRX
- Sector
- GPRO Consumer Discretionary
- EPRX
- Exchange
- GPRO Nasdaq
- EPRX NYSE
- Market Cap
- GPRO 118.4M
- EPRX 137.7M
- IPO Year
- GPRO 2014
- EPRX N/A
- Fundamental
- Price
- GPRO $1.51
- EPRX $5.49
- Analyst Decision
- GPRO Hold
- EPRX Strong Buy
- Analyst Count
- GPRO 1
- EPRX 2
- Target Price
- GPRO $1.50
- EPRX $11.50
- AVG Volume (30 Days)
- GPRO 20.4M
- EPRX 12.9K
- Earning Date
- GPRO 08-05-2025
- EPRX 08-07-2025
- Dividend Yield
- GPRO N/A
- EPRX N/A
- EPS Growth
- GPRO N/A
- EPRX N/A
- EPS
- GPRO N/A
- EPRX N/A
- Revenue
- GPRO $780,312,000.00
- EPRX N/A
- Revenue This Year
- GPRO N/A
- EPRX N/A
- Revenue Next Year
- GPRO $6.79
- EPRX N/A
- P/E Ratio
- GPRO N/A
- EPRX N/A
- Revenue Growth
- GPRO N/A
- EPRX N/A
- 52 Week Low
- GPRO $0.40
- EPRX $2.20
- 52 Week High
- GPRO $2.37
- EPRX $6.20
- Technical
- Relative Strength Index (RSI)
- GPRO 80.77
- EPRX N/A
- Support Level
- GPRO $0.75
- EPRX N/A
- Resistance Level
- GPRO $2.37
- EPRX N/A
- Average True Range (ATR)
- GPRO 0.18
- EPRX 0.00
- MACD
- GPRO 0.08
- EPRX 0.00
- Stochastic Oscillator
- GPRO 47.43
- EPRX 0.00
About GPRO GoPro Inc.
GoPro Inc is a United States-based company that is principally engaged in designing and providing cameras, mounts and accessories, lifestyle gear, applications, and subscriptions and services. The company sells products across the world through retailers, distributors, and on GoPro.com. Its hardware products are designed and developed in the United States, France, China, and Romania, and a majority of the manufacturing is outsourced to contract manufacturers located in China, Thailand, and Vietnam. Geographically, the company generates maximum revenue from the Americas, followed by Europe, Middle East and Africa (EMEA), and Asia and Pacific (APAC) region.
About EPRX EUPRAXIA PHARMACEUTICALS INC
Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals. Its product EP-104 is used for the treatment of osteoarthritis and eosinophilic esophagitis symptoms. The company leverages its proprietary Diffusphere technology to optimize drug delivery for applications with unmet medical needs.